NCT02544802View on ClinicalTrials.gov

Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee

PHASE1CompletedINTERVENTIONAL
Enrollment

4

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

January 31, 2019

Study Completion Date

January 31, 2019

Conditions
Osteoarthritis Knee
Interventions
DRUG

Adipose-Derived Mesenchymal Stem Cells

Trial Locations (1)

Unknown

Taipei Veterans General Hospital, Taipei

All Listed Sponsors
lead

Steminent Biotherapeutics Inc.

INDUSTRY

NCT02544802 - Mesenchymal Stem Cell Treatment for Primary Osteoarthritis Knee | Biotech Hunter | Biotech Hunter